GLAXOSMITH Notifies Of The Appointment Of A Non-Executive Director

People
359 VIEWS
Proshare - Facebook Proshare - Twitter Proshare - Linked In Proshare - WhatsApp
Proshare

Monday, November 04, 2019 / 05:37 PM / NSE / Header Image Credit: Lafarge


The Board of Directors of GlaxoSmithKline Consumer Nigeria Plc (GSK or the Company) wishes to announce the appointment of Mrs. Oludewa Edodo-Thorpe as a non-executive director on the board of the Company effective 5 December 2019.

Mrs. Edodo-Thorpe is a seasoned corporate and investment lawyer, who graduated with Bachelor's degree in law with honours from the University of Nigeria, Enugu Campus and a Master's Degree in Law, from the University of Lagos. She was called to the Nigerian Bar in 1979.

She joined the Nigerian Industrial Development Bank Ltd, (NIDB) now Bank of Industry Limited (BOI) after her national service and rose to increasing levels of responsibility until she was appointed the Company Secretary of NIDB Trustees Ltd (BOI Trustees Ltd) before disengaging from the Bank.

She commenced active Legal Practice specializing in Secured Credit Transactions, Corporate & Commercial Law and International Business Transactions. Apart from running a Firm of Legal Practitioners, she also doubles as the Chief Executive Officer of a Firm of Company Secretaries which handles the corporate meetings and compliance duties of many Companies.

Mrs. Edodo-Thorpe is currently the National Secretary of the National Co-ordinating Committee of the Shareholders' Associations; the body that co-ordinates the activities of the seven zones of the Zonal Shareholders' Associations. She is also a member of the Nigerian Bar Association (NBA), Capital Market Solicitors Association and the International Bar Association (IBA). She has attended many Conferences of both the IBA & NBA. She has served the Nigerian Capital Market community in various capacities including:

 

i.      Member, Technical Committee for the Review of the Investment and Securities Act (ISA) No. 45 of 1999.

ii.      Member, The Securities and Exchange Commission's Market - Wide Committee on e -Dividend.

iii.    Member, The Investment Management Sub Committee of the Securities and Exchange Commission's Capital Market Committee (CMC).

She is currently serving the Nigerian Capital Market community as a member of the Multiple Subscriptions Committee of the Securities and Exchange Commission.

She was a Commissioner in the Delta State House of Assembly Service Commission. She was a member of the Statutory Audit Committee of Union Home Savings and Loans Plc, a company which used to be a subsidiary of Union Bank Plc. She is a member of the Society for Corporate Governance Nigeria and a Fellow of the Institute of Directors (loD) Nigeria, where she was a member of many Committees.

She was, until recently, a Non-Executive Director in Lafarge Africa Plc, where she served for nine years (September 2008 to June 2017). She was a member of Risk Management & Ethics Committee, and the Property Optimization Committee.

She is an active member of the Soroptimist International, a Non-Government Organization for Professional women recognized by the United Nation, where she has served in many capacities. She is currently the Vice President, West and Central Africa Region, Soroptimist International Future Africa Federation. She is currently a Director on the Boards of Coastline Micro-Finance Bank Limited, where she is a member of the Credit and Risk Committees.

The Board is very confident that with her background, relevant experience and significant involvement in the capital market community, Mr. Edodo-Thorpe would add significant value to the quality and diversity of the Board of GlaxoSmithKline Consumer Nigeria Plc.

 

Visit GlaxoSmithKline Consumer Nigeria Plc in Proshare MARKETS

Graph - One Year Share Price Movement

Proshare Nigeria Pvt. Ltd.

 

Table: Unaudited Q2 2019 Results

Proshare Nigeria Pvt. Ltd.

 

Related News

1.      GLAXOSMITH Announces approved Change in its Supply Chain Model

2.      GLAXOSMITH declares N617.62 mln PAT in 2018 Audited Result; Proposes 50 Kobo Final Dividend

3.        GLAXOSMITH Declares N10mn LAT in Q3 2018 Results (SP:N11.10k)

4.        GLAXOSMITH Debunks Online Publication that the Company’s 2018 AFS is Unavailable

5.        GLAXOSMITH Notifies of its Board Meeting to Hold on Thursday 7th March 2019

6.        GLAXOSMITH Declares N10mn LAT in Q3 2018 Results (SP:N11.10k)

7.        GLAXOSMITH Records 10.39% Gain - What is Driving This Movement in Share Price?

8.       GLAXOSMITH declares N258.29m PAT in Q1 2018 Result,(SP:N24.00k)

9.        GlaxoSmithKline Consumer Nigeria Plc Announces Board Meeting Date and Closed Period

10.    GLAXOSMITH declares N651.61 Million Loss in Q3 2017 Result,(SP:N25.20k)

READ MORE:
Related News
SCROLL TO TOP